ImprimisRx launches compounded Antibiotic Formulation

Uncategorized

[ad_1] ImprimisRx today announced the availability of Fortisite, which includes a patent-pending compounded combination of tobramycin 1.5% and vancomycin 5%. According to a news release from the company, compounded topical antibiotic formulations may be appropriate to prescribe for patients with clinical needs that are unmet by FDA-approved drug products. Fortisite, which includes a compounded combination antibiotic…

Read More
Close up of an eye

How Do Your Eyes Feel?

Uncategorized

[ad_1] Myze is a next generation eye care engagement platform that helps identify, treat, and manage dry eyes throughout a patient’s dry eye journey. According to the news release, Myze enables “always available” screenings followed by frictionless access to products, services, and education. No more product overload and decision paralysis at retail locations. Myze makes…

Read More
Man suffering from eye strain

Not enough corneas: Fact or fiction?

Uncategorized

[ad_1] Donor corneal tissue for transplantation is something that most US corneal specialists typically do not worry about, because our eye banking system here is the envy of the world. We have many well-regarded, well-established and well-managed organizations doing an incredible job of serving our communities. We can treat our patients with confidence, knowing that…

Read More
Not enough corneas: Fact or fiction?

Vision impairment affects earnings and safety in Bangladesh

Uncategorized

[ad_1] Reviewed by Jennifer L. Patnaik, PhD Orbis International has focused on vision impairment related to workers in low- and middle-income countries. To no one’s surprise, unaddressed visual problems negatively affect both the level of safety and the earnings of workers in these underdeveloped countries. Simple, readily available solutions can profoundly impact poverty reduction, gender…

Read More
Vision impairment affects earnings and safety in Bangladesh

Eye trauma: Treatment trends and innovations

Uncategorized

[ad_1] Jeremy Tan, MD, an oculoplastic surgery specialist at the Dean McGee Eye Institute, details some the latest trends in eye trauma surgery at the Dean McGee Eye Institute, and how these treatments are making an impact on the lives of patients. “Traumas can be functionally disabling and also cosmetically disfiguring,” Tan explained, “We establish…

Read More
Eye trauma: Treatment trends and innovations

The Importance Of Eye Vision To Americans

Featured,Uncategorized

From seeing the faces of loved ones, to watching the sun come up and go down — these are a few things that Americans will most miss seeing if they lose sight. A new survey of 2000 Americans found respondents also would miss seeing their childs milestones (26%), nature (23%), their pets (22%), and their…

Read More
Elderly person wearing glasses

How To Find The Best LASIK Surgeon In NYC

Featured,Uncategorized

Before going in for any type of surgery, you need to consider risks, what to expect, and, above all, how to find a reputable LASIK surgeon. We want to make sure your laser eye surgery is a great experience for you, so we have compiled the reasons why Dr. Sandra Belmont is the best surgeon…

Read More
healthy vision

What Your Eye Color Can Say About Your Health

Uncategorized

Researchers found people who had vitiligo were less likely to have blue or grey eyes compared with people who did not. A 2012 review of research on vitiligo published in Nature found the autoimmune disorder, which causes a loss of skin color to mottled patches, was less prevalent in blue-eyed people. You are also a…

Read More
Close up of eyes of young woman with artistic makeup in the form of paint strokes.

Streamlining stem cells to treat macular degeneration

Uncategorized

[ad_1] As we age, so do our eyes; most commonly, this involves changes to our vision and new glasses, but there are more severe forms of age-related eye problems. One of these is age-related macular degeneration, which affects the macula — the back part of the eye that gives us sharp vision and the ability…

Read More
Illustration of cells

Aflibercept shown to work at higher dose, longer intervals

Uncategorized

[ad_1] Regeneron Pharmaceuticals Inc. this week announced that the primary endpoints were met in two pivotal trials investigating novel aflibercept 8 mg (Eylea) with 12- and 16-week dosing regimens in patients with diabetic macular edema (DME) and wet age-related macular degeneration (wAMD). The PHOTON trial in DME and the PULSAR trial in wAMD both demonstrated…

Read More
Scientists in lab - DNA Structure